Copper Cu 64 PSMA I&T

DRUG2 trials

Sponsors

Curium US LLC

Conditions

Biochemical Recurrence of Malignant Neoplasm of ProstateProstate AdenocarcinomaProstate Cancer

Phase 3

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Active, not recruitingNCT06235151

Curium US LLCProstate Adenocarcinoma, Prostate Cancer

Start: 2024-04-01End: 2026-09-01Target: 439Updated: 2026-08-14

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

CompletedNCT06235099

Curium US LLCBiochemical Recurrence of Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer

Start: 2024-04-01End: 2025-02-18Updated: 2026-02-18